Cargando…
Avacopan as First-Line Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Steroid-Sparing Option
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091582/ https://www.ncbi.nlm.nih.gov/pubmed/35570990 http://dx.doi.org/10.1016/j.ekir.2022.01.1065 |
| _version_ | 1784704955114848256 |
|---|---|
| author | Gabilan, Charlotte Pfirmann, Pierre Ribes, David Rigothier, Claire Chauveau, Dominique Casemayou, Audrey Huart, Antoine Schanstra, Joost Colombat, Magali Faguer, Stanislas Belliere, Julie |
| author_facet | Gabilan, Charlotte Pfirmann, Pierre Ribes, David Rigothier, Claire Chauveau, Dominique Casemayou, Audrey Huart, Antoine Schanstra, Joost Colombat, Magali Faguer, Stanislas Belliere, Julie |
| author_sort | Gabilan, Charlotte |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9091582 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90915822022-05-12 Avacopan as First-Line Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Steroid-Sparing Option Gabilan, Charlotte Pfirmann, Pierre Ribes, David Rigothier, Claire Chauveau, Dominique Casemayou, Audrey Huart, Antoine Schanstra, Joost Colombat, Magali Faguer, Stanislas Belliere, Julie Kidney Int Rep Research Letter Elsevier 2022-01-30 /pmc/articles/PMC9091582/ /pubmed/35570990 http://dx.doi.org/10.1016/j.ekir.2022.01.1065 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Gabilan, Charlotte Pfirmann, Pierre Ribes, David Rigothier, Claire Chauveau, Dominique Casemayou, Audrey Huart, Antoine Schanstra, Joost Colombat, Magali Faguer, Stanislas Belliere, Julie Avacopan as First-Line Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Steroid-Sparing Option |
| title | Avacopan as First-Line Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Steroid-Sparing Option |
| title_full | Avacopan as First-Line Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Steroid-Sparing Option |
| title_fullStr | Avacopan as First-Line Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Steroid-Sparing Option |
| title_full_unstemmed | Avacopan as First-Line Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Steroid-Sparing Option |
| title_short | Avacopan as First-Line Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Steroid-Sparing Option |
| title_sort | avacopan as first-line treatment in antineutrophil cytoplasmic antibody-associated vasculitis: a steroid-sparing option |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091582/ https://www.ncbi.nlm.nih.gov/pubmed/35570990 http://dx.doi.org/10.1016/j.ekir.2022.01.1065 |
| work_keys_str_mv | AT gabilancharlotte avacopanasfirstlinetreatmentinantineutrophilcytoplasmicantibodyassociatedvasculitisasteroidsparingoption AT pfirmannpierre avacopanasfirstlinetreatmentinantineutrophilcytoplasmicantibodyassociatedvasculitisasteroidsparingoption AT ribesdavid avacopanasfirstlinetreatmentinantineutrophilcytoplasmicantibodyassociatedvasculitisasteroidsparingoption AT rigothierclaire avacopanasfirstlinetreatmentinantineutrophilcytoplasmicantibodyassociatedvasculitisasteroidsparingoption AT chauveaudominique avacopanasfirstlinetreatmentinantineutrophilcytoplasmicantibodyassociatedvasculitisasteroidsparingoption AT casemayouaudrey avacopanasfirstlinetreatmentinantineutrophilcytoplasmicantibodyassociatedvasculitisasteroidsparingoption AT huartantoine avacopanasfirstlinetreatmentinantineutrophilcytoplasmicantibodyassociatedvasculitisasteroidsparingoption AT schanstrajoost avacopanasfirstlinetreatmentinantineutrophilcytoplasmicantibodyassociatedvasculitisasteroidsparingoption AT colombatmagali avacopanasfirstlinetreatmentinantineutrophilcytoplasmicantibodyassociatedvasculitisasteroidsparingoption AT faguerstanislas avacopanasfirstlinetreatmentinantineutrophilcytoplasmicantibodyassociatedvasculitisasteroidsparingoption AT bellierejulie avacopanasfirstlinetreatmentinantineutrophilcytoplasmicantibodyassociatedvasculitisasteroidsparingoption |